Stay updated on CT-P13 SubQ in IBD: Pharmacokinetics, Efficacy, Safety Clinical Trial
Sign up to get notified when there's something new on the CT-P13 SubQ in IBD: Pharmacokinetics, Efficacy, Safety Clinical Trial page.

Latest updates to the CT-P13 SubQ in IBD: Pharmacokinetics, Efficacy, Safety Clinical Trial page
- ChecktodayChange DetectedThe site footer now shows revision v3.8.0 instead of v3.7.2; the study record still displays a 403 Forbidden error.SummaryDifference0.2%

- Check7 days agoChange DetectedThe ClinicalTrials.gov record for a Phase I study of subcutaneous versus intravenous CT-P13 in Crohn’s disease and ulcerative colitis is now displayed. It includes the study design, eligibility criteria, treatment arms, outcome measures, results-related dates, and study documents.SummaryDifference59%

- Check14 days agoChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check21 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1; the study record remains inaccessible behind a 403 error.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page now shows a new revision label: Revision: v3.7.0. Several older study document entries were removed or reorganized, indicating an update to the study record and its referenced materials.SummaryDifference20%

- Check63 days agoChange DetectedThe revision tag on the page updated from v3.6.5 to v3.6.6, signaling a new build of the site. This update likely includes minor fixes or improvements without changing the displayed study information.SummaryDifference0.1%

Stay in the know with updates to CT-P13 SubQ in IBD: Pharmacokinetics, Efficacy, Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CT-P13 SubQ in IBD: Pharmacokinetics, Efficacy, Safety Clinical Trial page.